摘要
目的 探讨肝移植治疗终末期肝病的临床效果。方法 在过去 2年内 ,70例终末期肝病患者接受了 72例次原位肝移植手术 ,其中包括 1例小儿减体肝移植。结果 手术近期死亡 18例( 2 5 .7% ) ,随访期间死亡 14例 ( 2 6 .9% ) ,术后胆道并发症发生率 2 3 % ,肝动脉并发症 2 0 %。术后生存时间超过 6个月者 30例 ,超过 1年者 17例 ,其中肝癌组 ( 31例 ) ,有 9例术后生存已超过 6个月 ,3例超过 1年。结论 减少外科手术并发症是提高肝移植手术成功率以及长期存活的关键。对于肝硬化合并原发性肝癌的患者 。
Objective To study the efficacy of orthotopic liver transplantation (OLT) in the treatment of end stage liver disease. Methods Seventy patients with end stage liver disease underwent liver transplantation of 72 times in the past two years, including one case of child with reduced size liver transplantation, 37 cases of cirrhosis resulting from hepatitis B, 30 cases of hepatic cancer. Results A total of 72 times of OLT were performed in 70 patients. The perioperative mortality was 25.7 ?% (18 cases). During the period of follow up, 14 of the 52 patients died. The occurrence of bile duct complications and hepatic artery complications was 23?% and 20?% respectively after operation. The survival time in 30 cases was over 6 months and in 17 cases over one year. Among the 31 cases of hepatocellular carcinoma, the survival time in 9 cases was over 6 months and in 3 cases over one year after operation. Conclusion The liver transplantation was an effective means in the treatment of end stage liver diseases. The preoperative status of the recipient, donor liver quality, and technical aspects of the operation are the most critical determinants of early outcome.
出处
《中华器官移植杂志》
CAS
CSCD
北大核心
2001年第2期75-77,共3页
Chinese Journal of Organ Transplantation
关键词
肝移植
肝硬化
原发性肝癌
肝动脉狭窄
病例报告
Liver transplantation
Hepatic cirrhosis
Primary hepatocellular carcinoma
Hepatic artery stenosis
